VistaGen Therapeutics - 53 Year Dividend History | VTGN
Historical dividend payout and yield for VistaGen Therapeutics (VTGN) since 1971. The current TTM dividend payout for VistaGen Therapeutics (VTGN) as of November 19, 2024 is $0.00. The current dividend yield for VistaGen Therapeutics as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.074B |
$0.001B |
|
VistaGen Therapeutics, Inc. is a biotechnology company. It is engaged in developing and commercializing product candidates for diseases and disorders involving the central nervous system. The company's lead product candidate consists of AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of major depressive disorder. VistaGen Therapeutics, Inc. is headquartered in South San Francisco, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
